General MedicationsINJECTIONGeneric
ANZEMET
DOLASETRON MESYLATE
Standard Dose
100MG/5ML (20MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: 901 REQUIRED Marketing status: Discontinued
Summary
Approval overview ANZEMET is listed in Drugs@FDA under application 020624 (NDA).
Review priority: 901 REQUIRED Marketing status: Discontinued Active ingredient DOLASETRON MESYLATE Form and strength INJECTABLE;INJECTION - 100MG/5ML (20MG/ML) Sponsor VALIDUS PHARMS Submission history Latest submission status date: 2014-09-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview ANZEMET is listed in Drugs@FDA under application 020624 (NDA). Review priority: 901 REQUIRED Marketing status: Discontinued Active ingredient DOLASETRON MESYLATE Form and strength INJECTABLE;INJECTION - 100MG/5ML (20MG/ML) Sponsor VALIDUS PHARMS Submission history Latest submission status date: 2014-09-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: 901 REQUIRED
Interaction Notes
- No interaction notes stored yet.